Reports and Papers

Regulating Nanomaterials: A Transatlantic Agenda

Briefing Paper
Robert Falkner, Linda Breggin, Nico Jaspers, John Pendergrass and Read Porter, September 2009

The US and EU need to strengthen international regulatory cooperation if the commercial promises of nanotechnologies are to be fulfilled.
Persistent scientific uncertainty could limit the effectiveness of existing regulatory frameworks and risk assessment approaches. International efforts to create scientific building blocks for risk assessment of nanomaterials should be expanded.
The EU and US need to provide significantly increased funding for research into the environmental, health and safety risks of nanomaterials and promote greater coordination of such funding at an international level.
Governments should strengthen existing mandatory reporting requirements for nanomaterials in commercial use and, where necessary, create new ones.
US and EU authorities should explore the implications of potentially diverging consumer labelling requirements for nanomaterials, given international trade obligations, and work towards common approaches on standards for labelling.
In view of the ongoing and accelerating globalization of nanotechnologies, the EU and the US should complement existing international initiatives with the development of international governance capacity in other areas (UNEP, WHO), not least to ensure that developing countries are more involved in international decision-making.